CLASS ACTION UPDATE for WWE, TLRY and INO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / March 16, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

World Wrestling Entertainment, Inc. (NYSE:WWE)
WWE Lawsuit on behalf of: investors who purchased February 7, 2019 – February 5, 2020
Lead Plaintiff Deadline: May 5, 2020
Join the action: https://www.zlk.com/pslra-1/world-wrestling-entertainment-inc-loss-form?wire=3&prid=5703

About the WWE lawsuit: Throughout the class period, World Wrestling Entertainment, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: Defendants perpetrated a fraudulent scheme which: (i) deceived the investing public regarding WWE's business and prospects; (ii) artificially inflated the price of WWE Class A common stock; (iii) permitted certain senior executives of WWE to sell more than $282 million worth of their personally held shares at fraud inflated prices; and (iv) caused the public to purchase WWE Class A common stock at artificially inflated prices.

To learn more about the World Wrestling Entertainment, Inc. class action, contact jlevi@levikorsinsky.com.

Tilray, Inc. (NASDAQ:TLRY)
TLRY Lawsuit on behalf of: investors who purchased January 15, 2019 – March 2, 2020
Lead Plaintiff Deadline: May 5, 2020
Join the action: https://www.zlk.com/pslra-1/tilray-inc-loss-form?wire=3&prid=5703

About the TLRY lawsuit: During the class period, Tilray, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) the purported advantages of the marketing and revenue sharing agreement with Authentic Brands Group (the "ABG Agreement")were significantly overstated; (ii) the under performance of the ABG Agreement would foreseeably have a significant impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

To learn more about the Tilray, Inc. class action, contact jlevi@levikorsinsky.com.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO)
INO Lawsuit on behalf of: investors who purchased February 14, 2020 – March 9, 2020
Lead Plaintiff Deadline: May 12, 2020
Join the action: https://www.zlk.com/pslra-1/inovio-pharmaceuticals-inc-loss-form?wire=3&prid=5703

According to a filed complaint, throughout the class period, defendants made misleading statements about the company's development of a purported vaccine for the novel coronavirus, artificially inflating the company's share price and resulting in significant investor losses.

To learn more about the Inovio Pharmaceuticals, Inc. class action, contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 581015